Centene (CNC) reported a significant Q2 2025 earnings miss, posting a loss of $0.16 per share against an estimated $0.68, marking a -123.53% surprise. Despite this, the healthcare company's revenues robustly beat expectations, reaching $48.74 billion, a 10.93% surprise. The substantial earnings shortfall, coupled with the stock's 55.8% year-to-date underperformance relative to the S&P 500, has contributed to a Zacks Rank #5 (Strong Sell), with future share price movement largely dependent on management's commentary.
Centene Corporation (CNC) has reported a significant divergence in its Q2 2025 financial results, with a robust top-line performance overshadowed by a severe collapse in profitability. The company posted revenues of $48.74 billion, a 10.93% beat against consensus estimates and a notable increase from $39.84 billion in the prior-year quarter. However, this growth was negated by a substantial earnings miss, resulting in an adjusted loss of $0.16 per share, which stands in stark contrast to the expected profit of $0.68 and the $2.42 earnings per share reported a year ago. This disconnect has exacerbated the stock's pronounced market underperformance, with shares having declined 55.8% year-to-date while the S&P 500 gained 8.2%. The negative sentiment is further solidified by a pre-existing unfavorable trend in earnings estimate revisions, culminating in a Zacks Rank #5 (Strong Sell) designation, which signals expectations of continued near-term weakness pending clarification from management.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment